[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100276905":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":28,"locations":34,"responsibleParty":48,"collaborators":50,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":10,"enrollmentInfo":71,"targetDuration":10,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":79,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Elderly cancer patient cohort",null,"Patients aged 70 years or older, who had diagnosis of cancer in participating sites (including hematologic malignancies), and referred to a geriatrician for geriatric assessment (GA)",[13],"Other: Extensive GA",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Extensive GA","GA includes an evaluation of nine domains according to international recommendations :\n\n* functional status (six-item Activities of Daily Living (ADL) score, Instrumental Activities of Daily Living (IADL))\n* mobility (timed get-up-and-go test, one-leg standing balance test, history of fall)\n* nutritional status (French National Authority of Health guidelines, weight loss body mass index (BMI), Mini Nutritional Assessment, albumin )\n* cognitive status (Mini-Mental State Examination (MMSE), history of dementia, confusion)\n* mood (Mini-Geriatric Depression Scale (Mini-GDS), symptoms of anxiety, depression (DSM V))\n* comorbidities (CIRS G)\n* polypharmacy (number of medications)\n* social environment (primary caregiver, support at home, friends , family, living alone)\n* urinary and\u002For fecal incontinence",[9],[20,23,26],{"name":21,"affiliation":5,"role":22},"PHILIPPE CAILLET, MD","PRINCIPAL_INVESTIGATOR",{"name":24,"affiliation":5,"role":25},"ELENA PAILLAUD, MD-PhD","STUDY_DIRECTOR",{"name":27,"affiliation":5,"role":25},"FLORENCE CANOUI-POITRINE, MD-PhD",[29],{"name":21,"role":30,"phone":31,"phoneExt":32,"email":33},"CONTACT","(0)149814707","+33","philippe.caillet@aphp.fr",[35],{"facility":36,"status":37,"city":38,"state":10,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":10},"Henri Mondor Hospital","RECRUITING","Créteil","94010","France","FR",{"type":43,"coordinates":44},"Point",[45,46],2.46569,48.79266,{"lat":46,"lon":45},{"type":49,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[51,54,57,59],{"name":52,"class":53},"National Cancer Institute, France","OTHER_GOV",{"name":55,"class":56},"Oncogeriatric Coordination Unit (UCOG) - Sud-Val-de-Marne","UNKNOWN",{"name":58,"class":56},"Oncogeriatric Coordination Unit (UCOG) - Paris-Ouest",{"name":60,"class":6},"Cancéropôle Ile De France","100276905","elderly-cancer-patient-100276905",false,"NCT02884375","Elderly CAncer Patient","Elderly Cancer Patient: ELCAPA Cohort Survey","ELCAPA","Inclusion Criteria:\n\n* Patient aged 70 years or older\n* Diagnosed cancer at all stage\n* Referred to a geriatrician for GA\n* Given oral non-opposition from patient or a legally mandated person\n\nExclusion Criteria:\n\n* Oral opposition","ALL","70 Years",{"count":72,"type":73},3000,"ESTIMATED","OBSERVATIONAL","The management of older patients with cancer has become a major public health concern in Western countries because of the aging of the population and steady increase in cancer incidence with advancing age. Cancer treatment of aged patients is complex due to comorbidities, polypharmacy and functional status. The heterogeneity of the older population in terms of comorbidities and functional status may explain the difficulty in establishing management recommendations.\n\nStudy hypothesis is that a geriatric consultation using Geriatric Assessment (GA) can evaluate patient's resource and strengths, in order to help oncologist to define the most effective treatment. The GA developed by geriatricians and recommended by the International Society of Geriatric Oncology (SIOG), is a multidimensional assessment of general health status; comorbidities; functional status; nutritional, cognitive, psychological, and social parameters; and medications. The GA uses validated geriatric scales to produce an inventory of problems, which can then serve to develop an individualized geriatric intervention plan; it may be an important step in selecting elderly patients for cancer screening and treatment.\n\nThe objectives are:\n\n* To assess the role of GA for decision making process for older patients with cancer\n* To identify geriatric and oncologic factors associated with overall survival, treatment feasibility, toxicities, morbidities\n* To develop and\u002For validate screening tests for frailty in geriatric oncology\n* To develop and validate frailty classifications\n\nMethod: The ELCAPA (ELderly CAncer PAtient) survey is a French multicentric prospective study that includes all patients age 70 years or older who has a diagnosis of solid cancer or hematologic malignancies in French hospitals",[77,78],"Hematologic Malignancies","Solid Cancer",[80,81,82,83,84],"Elderly","Cancer","Geriatric assessment","Treatment","Epidemiology","2016-08-25",{"date":87,"type":73},"2016-08-31",{"date":89,"type":10},"2010-09",{"date":91,"type":73},"2027-11",{"name":5,"class":6},1]